Curis (CRIS) - Total debt

#9673

Rank

HK$0.20 B

Marketcap

🇺🇸 United States

Country

HK$23.95

Share price

0.33%

Change (1 day)

-75.84%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Curis - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year	Total debt	Change
2023-12-31	HK$21.82 M	-29.13%
2022-12-31	HK$30.79 M	-21.65%
2021-12-31	HK$39.29 M	-33.84%
2020-12-31	HK$59.39 M	4494.37%
2019-12-31	HK$1.29 M	-99.53%
2018-12-31	HK$0.27 B	-14.41%
2017-12-31	HK$0.32 B	110.82%
2016-12-31	HK$0.15 B	-17.77%
2015-12-31	HK$0.18 B	-14.67%
2014-12-31	HK$0.21 B	-7.36%
2013-12-31	HK$0.23 B	2.44%
2012-12-31	HK$0.23 B
2008-12-31	N/A	-100%
2007-12-31	HK$3.14 M	-79.55%
2006-12-31	HK$15.39 M	-65.95%
2005-12-31	HK$45.21 M	-15.07%
2004-12-31	HK$53.24 M	21.43%
2003-12-31	HK$43.84 M	-54.71%
2002-12-31	HK$96.81 M	17.49%
2001-12-31	HK$82.4 M	72.45%
2000-12-31	HK$47.78 M	353.36%
1999-12-31	HK$10.54 M

Total debt for similar companies or competitors

Company	Total debt/th>	differencediff.	Country
Exelixis EXEL	HK$1.51 B	5,864.57%	🇺🇸 USA
Emergent BioSolutions EBS	HK$5.15 B	20,225.15%	🇺🇸 USA
Spectrum Pharmaceuticals SPPI	HK$0.22 B	784.66%	🇺🇸 USA
Celldex Therapeutics CLDX	HK$24 M	-5.31%	🇺🇸 USA
Pfizer PFE	HK$517.93 B	2,043,366.26%	🇺🇸 USA
Bristol-Myers Squibb BMY	HK$399.62 B	1,576,587.12%	🇺🇸 USA
Cel-Sci CVM	HK$94.32 M	272.15%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions